Novartis’ Adaptive Monitoring RBM Model
September 3rd 2015The world of RBM is continually changing as biopharmaceutical enterprises are dabbling into different approaches and methods. There are several outsourced models that exist, when approaching RBM, such as integrating cloud-based solutions to provide centralized monitoring teams with analytics, or fully outsourcing RBM functions and technologies to CROs. However, some companies, such as Novartis, appear to be in-sourcing their RBM technologies and functions.
Barriers to Clinical Trial Recruitment and Possible Solutions: A Stakeholder Survey
September 3rd 2015A staggering number of clinical trials fail to meet recruitment goals, which leads to delays, early trial termination, or inability to draw conclusions at trial completion due to loss of statistical power.